De-risk your inhaled drug development

Unlock your inhaled drug development with data that goes further.

Inhalation Sciences delivers exceptionally detailed insights – early in development, empowering you to make confident, informed decisions.

An FDA-funded study shows that DissolvIt^® has the potential to generate data that can be used to predict clinical plasma profiles.

Why work with us?

• Gain rich, clinically relevant data earlier in development

• Reduce uncertainty and improve trial outcomes

• Advance with a proven platform for smarter and faster progress

Still exploring?

Download our paper about DissolvIt^®, and find out how we can deliver better data for your pre-clinical trials.

Ulf Wedenberg

Chief Commercial Officer